Abbott 'confident' its tests can detect omicron variant
As countries around the world prepare for the spread of the omicron variant, one of the U.S.'s largest manufacturers of COVID-19 tests says it is "confident" its products will detect the new strain.
"Abbott has been intently monitoring the mutations of COVID-19 so we can ensure our tests can detect them," Abbott Laboratories said in a statement Saturday night. "We have already conducted an assessment of the Omicron variant and we're confident our rapid and PCR tests can detect the virus. While the Omicron variant contains mutations to the spike protein, Abbott's rapid and PCR tests do not rely on the spike proteins to detect the virus."
Abbott said both its ID NOW tests, used by medical professionals, and BinaxNOW tests, sold for at-home use, have been shown to detect the virus.
The company is currently manufacturing 100 million tests a month for use worldwide. The U.S. government is among those to have purchased the tests, with President Joe Biden announcing in late September that millions of dollars worth of tests would be purchased.
The omicron strain, first detected in southern Africa, has now been identified in several European countries. It was declared a variant of concern by the World Health Organization on Friday.